Reply to letter by Bamford et al. regarding the article: Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Piccini, JP; Garg, J; Hellkamp, A; Pieper, KS; Patel, MR

Published Date

  • May 14, 2019

Published In

Volume / Issue

  • 40 / 19

Start / End Page

  • 1568 -

PubMed ID

  • 30476238

Pubmed Central ID

  • 30476238

Electronic International Standard Serial Number (EISSN)

  • 1522-9645

Digital Object Identifier (DOI)

  • 10.1093/eurheartj/ehy743

Language

  • eng

Conference Location

  • England